ALFA FinderNSE filing, NSE: ASPIRE. Summary written from the filing by ALFA Finder's alert engine.
Aspire & Innovative Advertising Ltd: key numbers
- Share price
- ₹15.55
- Market cap
- ₹23.60 Cr
- Revenue (annual)
- ₹176.2 Cr
- Net profit (annual)
- ₹2.56 Cr
- P/E (TTM)
- 9.2×Sector 43.9×
- Promoter holding
- 72.77%+0.42% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Aspire & Innovative Advertising Ltd
All →Aspire & Innovative Advertising Other Announcement
Aspire & Innovative Advertising filed its Reg 76 Reconciliation of Share Capital Audit Report for Q1 FY27. It is routine compliance paperwork with no transaction or business event.
Aspire & Innovative Advertising Other Announcement
Aspire & Innovative Advertising Limited submitted a Structured Digital Database (SDD) Compliance Certificate, confirming adherence to SEBI PIT Regulations for the period ending 31st August 2026.
Aspire & Innovative Advertising Annual General Meeting
Aspire & Innovative Advertising Limited held its 9th Annual General Meeting on August 26, 2026. The meeting covered routine business and director appointments.
Aspire & Innovative Advertising Annual General Meeting
Aspire & Innovative Advertising Limited scheduled its 9th Annual General Meeting for August 26, 2026. The board approved the meeting notice, Director's Report, and appointed a Scrutinizer.
Aspire & Innovative Advertising H1 FY26 Results: Net Profit ₹0.9 Cr, Down 59.1% YoY
Aspire & Innovative Advertising Ltd reported revenue from operations of ₹60 Cr (-40.1% YoY) and net profit of ₹0.9 Cr (-59.1% YoY) for H1 FY26.
- Key figure
- Net profit ₹0.9 Cr · -59.1% YoY
Aspire & Innovative Advertising Business Update
Aspire & Innovative Advertising Limited reported ₹177 Crore revenue for FY25-26. The company successfully diversified into B2B, E-commerce, and GeM platforms to reduce NBFC concentration risks.
Other board meeting date announcements
All →Arvaya Healthcare Board Meeting Date
Arvaya Healthcare Ltd intimated a board meeting on November 13, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. The trading window remains closed until 48 hours after results are declared.
SI Capital & Financial Services Board Meeting Date
S.I. Capital will hold a board meeting on 12 November 2026 to consider unaudited standalone quarterly results. This is a prior intimation for the meeting.
Axel Polymers Board Meeting Date
Axel Polymers will hold a board meeting on 13 November 2026 to consider unaudited half-year results. The trading window stays closed until 48 hours after results.
FlySBS Aviation Board Meeting Date
FlySBS Aviation has scheduled a board meeting for 11 November 2026 to consider unaudited half-yearly results for the period ended September 2026. The trading window is not closed.
Shri Krishna Devcon Board Meeting Date
Shri Krishna Devcon informs BSE of a board meeting on 14 November 2026 to consider quarterly and half-year unaudited results. The trading window stays closed until 48 hours after results are declared.
Cian Healthcare Board Meeting Date
Cian Healthcare intimated that its board will meet on November 13, 2026, to consider unaudited standalone and consolidated results for the half year ended September 30, 2026. The trading window closes from October 1 until 48 hours after the results.